Daito Pharmaceutical Co (TSE:4577) YoY EBITDA Growth : -11.52% (As of Feb. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Daito Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was -11.52%.

Daito Pharmaceutical Co's EBITDA per Share for the three months ended in Feb. 2024 was 円72.51.

Daito Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Daito Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co YoY EBITDA Growth Chart

Daito Pharmaceutical Co Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

YoY EBITDA Growth

Get a 7-Day Free Trial

4.93

11.39

-0.79

9.04

-13.72

Daito Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
YoY EBITDA Growth	Get a 7-Day Free Trial															-30.30	32.22	-25.50	-0.81	-11.52

Daito Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Daito Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in May. 2023 is calculated as:

	YoY EBITDA Growth (A: May. 2023 )
=	(EBITDA per Share (A: May. 2023 )	-	EBITDA per Share (A: May. 2022 ))	/	\| EBITDA per Share (A: May. 2022 ) \|
=	(565.923	-	655.911)	/	\| 655.911 \|
=	-13.72 %

Daito Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

	YoY EBITDA Growth (Q: Feb. 2024 )
=	(EBITDA per Share (Q: Feb. 2024 )	-	EBITDA per Share (Q: Feb. 2023 ))	/	\| EBITDA per Share (Q: Feb. 2023 )) \|
=	(72.507	-	81.946)	/	\| 81.946 \|
=	-11.52 %

Daito Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Daito Pharmaceutical Co (TSE:4577) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

326 Yokamachi, Toyama, JPN, 939-8567

Website

http://www.daitonet.co.jp

Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines